Stay updated with breaking news from Third Party Observation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Singapore-- Third Party Observation submitted to World Intellectual Property Organization (WIPO) relating to 2023 claim disclosed in Horizon 2007 patent filing.
On 18 March 2022, the Patent (Amendment) Act 2022 [Act A1649] (“Amending Act”) came into force in Malaysia. This Amending Act brings about a significant revamp of the PatentsAct 1983. However, there are several sections and paragraphs within the Amending Act that will only come into operation later.
The Patent (Amendment) Act 2022 ComesInto Force In Malaysia. Legal News and Analysis - Malaysia - Intellectual Property -
To embed, copy and paste the code into your website or blog: A variety of artificial intelligence (AI) technologies exist and are being used in biopharma (e.g., discovery and development of drugs, optimization of clinical trial design, identification of novel biological targets and pathways of interest, analysis and use of biomedical, clinical, and patient data, and many others). As in most industries, AI will play an increasingly larger role in biopharma patents. However, there are a number of challenges of AI in biopharma patents. One of these challenges that has recently come to the forefr...
To embed, copy and paste the code into your website or blog: Dr. Stephen Thaler created an artificial-intelligence algorithm – named Device for the Autonomous Bootstrapping of Unified Sentience (DABUS) – that includes multiple neural networks (each trained in a given linguistic subspace) that are dynamically connected using controlled chaos. The AI included a novelty filter and foveator network to identify predicted novel sentiments having at least a target utility. Dr. Thaler filed patent applications on two technologies based on DABUS outputs around the globe. The only inventor that was...